全外显子组测序揭示DNA损伤修复缺陷是成人弥漫性胶质瘤发生的主要因素
DDRd可能作为胶质瘤发生的根本机制而非随机继发事件。
要点
- 特征1(88%,衰老相关)、特征3(52%,同源重组相关)、特征15(56%,错配修复相关)最常见。
- 每个样本均存在至少1个DDR基因的胚系或体细胞改变,MLH1 rs1800734最常见。
核心结论
- DDRd可能作为胶质瘤发生的根本机制,而非随机继发事件。
研究设计与样本
- 分析突变特征与诊断年龄、分子亚型及突变负荷的关联,并检测所有样本的胚系/体细胞DDR基因突变及微卫星不稳定(MSI)状态。
- 利用TCGA公开数据验证突变特征流行率。
主要发现
- 每例肿瘤具有独特的突变特征组合,最常见的为特征1(88%,衰老相关)、特征3(52%,同源重组相关)和特征15(56%,错配修复相关)。
- 特征1的权重与年龄正相关(r=0.43),DDRd特征的累积权重与年龄负相关(r=-0.16)。
- 每个受试者至少存在1个DDR基因的胚系/体细胞改变,最常见为MLH1风险单核苷酸多态性rs1800734。
- rs1800734-AA基因型具有更高的DDRd累积权重及更高的突变负荷;TP53是最常见的体细胞改变DDR基因;24%的肿瘤观察到MSI。
关键数值与推荐
- 特征1权重与年龄相关系数r=0.43,DDRd特征累积权重与年龄相关系数r=-0.16。
- MSI见于24%的肿瘤。
临床怎么用
- 对成人弥漫性胶质瘤患者可考虑评估DDRd相关突变特征,以辅助理解肿瘤发生机制。
- MLH1 rs1800734-AA基因型与更高DDRd累积权重及突变负荷相关,可能作为风险分层参考。
- MSI状态与突变负荷等无显著关联,不建议单独依据MSI判断DDRd程度。
局限性
- MSI状态与突变负荷、rs1800734或DDRd特征累积权重无显著关联,机制尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Processes that cause or contribute to cancer, such as aging, exposure to carcinogens, or DNA damage repair deficiency (DDRd), create predictable and traceable nucleotide alterations in one's genetic code (termed "mutational signatures"). Large studies have previously identified various such mutational signatures across cancers that can be attributed to the specific causative processes. To gain further insight into the processes in glioma development, the authors analyzed mutational signatures in adult diffuse gliomas (DGs). METHODS: Twenty-five DGs and paired blood samples were whole exome sequenced. Somatic mutational signatures were identified using 2 different methods. Associations of the signatures with age at diagnosis, molecular subset, and mutational load were investigated. As DDRd-related signatures were frequently observed, germline and somatic DDR gene mutations as well as microsatellite instability (MSI) status were determined for all samples. For validation of signature prevalence, publicly available data from The Cancer Genome Atlas (TCGA) were used. RESULTS: Each tumor had a unique combination of signatures. The most common signatures were signature 1 (88%, aging related), signature 3 (52%, homologous recombination related), and signature 15 (56%, mismatch repair related). Eighty-four percent of the tumors contained at least 1 DDRd signature. The findings were validated using public TCGA data. The weight of signature 1 positively correlated with age (r = 0.43) while cumulative weight of DDRd signatures negatively correlated with age (r = -0.16). Each subject had at least 1 germline/somatic alteration in a DDR gene, the most common being the risk single nucleotide polymorphism rs1800734 in MLH1. The rs1800734-AA genotype had a higher cumulative DDRd weight as well as higher mutational load; TP53 was the most common somatically altered DDR gene. MSI was observed in 24% of the tumors. No significant associations of MSI status with mutational load, rs1800734, or the cumulative weight of DDRd signatures were identified. CONCLUSIONS: Current findings suggest that DDRd may act as a fundamental mechanism in gliomagenesis rather than being a random, secondary event.
引用
- Ülgen E, Can Ö, Bilguvar K, et al. Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas. J Neurosurg. 2019. PMID: 30952131. doi:10.3171/2019.1.JNS182938
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。